Resistance Changes of Escherichia Coli to Cephalosporin in Erbil

Author: Yad Sirwan1
1Department of Biology, Faculty of Education, Tishk International University, Erbil, Iraq

Abstract: Antibiotic resistance is a topic that is constantly being researched, and numerous studies are published each year with new data that can change or redefine our perspective on the problem. The emergence and spread of drug-resistant pathogens with new resistance mechanisms, leading to antimicrobial resistance, continue to jeopardize our ability to treat common infections. This necessitated the need for understanding the mechanism of action in each country due to the environmental changes. The study aimed at documenting the resistance of E. coli to Cephalosporin in Erbil, Kurdistan Region of Iraq. The study covers the periods from August to December 2018. Two hundred and two (202) samples were collected from infected patients in Erbil from different specimens. Four different groups of cephalosporin were tested against the resistance of E. coli. Ineffectiveness of the antibiotics used against E. coli was reported. E. coli is becoming stronger every month, according to our findings. The rising increase in the resistance of E. coli is a result of resistance to fluoroquinolones in E. coli, which causes other resistance mechanisms because it is often linked to other commonly used medicines. There is a need for proper investigation of E. coli resistance to the currently used antibiotic in each country because the continued resistance might require to change guidance of many severe infections. Continued research on medicinal plants is also needed to develop a compound against resistant microorganisms.

Download the PDF Document

Doi: 10.23918/eajse.v7i2p186

Published: March 6, 2022


Abdulrahman, M. (2021). Antioxidant, alpha glucosidase and antibacterial evaluation of Syzygium mytifolium (Roxb.) Walp. Plant Science Today, 8(2), 410-415.

Abdulrahman, M. D., Abdullahi, F., Uwais, U. U., Tahir, S. M., Abdulkadir, S., Ibrahim, B., Muhammad, U. (2019). Macroscopic and microscopic examinations of fungi associated with Ipomoea Batatas In Kaduna State, Northern Nigeria. Annals Food Science and Technology, 20(4), 909-915.

Abdulrahman, M. D., Hasan Nudin, N., Khandaker, M. M., Ali, A. M., & Mat, N. (2019). In vitro biological investigations on Syzygium polyanthum cultivars. International Journal of Agriculture and Biology, 22(6), 1399-1406.

Bader, M. S., Hawboldt, J., & Brooks, A. (2010). Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgraduate Medicine, 122(6), 7-15.

Dalhoff, A. (2012). Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdisciplinary Perspectives on Infectious Diseases, 10.1155/2012/976273.

Drawz, S. M., & Bonomo, R. A. (2010). Three decades of β-lactamase inhibitors. Clinical Microbiology Reviews, 23(1), 160-201.

Huttner, A., Harbarth, S., Carlet, J., Cosgrove, S., Goossens, H., Holmes, A., . . . Pittet, D. (2013). Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrobial Resistance and Infection Control, 2(1), 1-13.

Jasovský, D., Littmann, J., Zorzet, A., & Cars, O. (2016a). Antimicrobial Resistance. Development Dialogue,2.

Jasovský, D., Littmann, J., Zorzet, A., & Cars, O. (2016b). Antimicrobial resistance—a threat to the world’s sustainable development. Upsala Journal of Medical Sciences, 121(3), 159-164.

Kayfi, S., & Abdulrahman, M. D. (2021). Ethnopharmacology of Plants in Choman, The Kurdistan Region of Iraq. Applied Biological Research, 23(4), 322-330.

Lehman, D. C. (2014). Biochemical identification of gram-negative bacteria. (5th .ed). Diagnostic Microbiology.

Mahmoud, A. D., Labaran, I., & Yunusa, A. (2020). Ethnobotany of medicinal plants with antimalarial potential in Northern Nigeria. Ethnobotany Research and Applications, 19(2020), 1-8.

Mahmoud, A. D., & Abba, A. (2021). Ethnomedicinal survey of plants used for management of inflammatory diseases in Ringim local government, Jigawa State, Nigeria. Ethnobotany Research and Applications, 22, 1-27.

McCloskey, B., Endericks, T., Catchpole, M., Zambon, M., McLauchlin, J., Shetty, N., . . . Crook, P. (2014). London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology. The Lancet, 383(9934), 2083-2089.

Meyer, E., Schwab, F., Schroeren-Boersch, B., & Gastmeier, P. (2010). Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: Secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Critical Care, 14(3), 1-9.

Park, Y. S., Adams-Haduch, J. M., Shutt, K. A., Yarabinec III, D. M., Johnson, L. E., Hingwe, A., Doi, Y. (2012). Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States. Antimicrobial Agents and Chemotherapy, 56(4), 1870-1876.

Rafalskiy, V., Pushkar, D., Yakovlev, S., Epstein, O., Putilovskiy, M., Tarasov, S., Gorelysheva, N. (2020). Distribution and antibiotic resistance profile of key Gram-negative bacteria that cause community-onset urinary tract infections in the Russian Federation: Resource multicentre surveillance 2017 study. Journal of Global Antimicrobial Resistance, 21, 188-194.

Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Carmeli, Y. (2018). Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infectious Diseases, 18(3), 318-327.

Walsh, T. R., & Toleman, M. A. (2012). The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. Journal of Antimicrobial Chemotherapy, 67(1), 1-3.